Plasma/serum activity of SOD has been, in turn, found either more markedly decreased among patients with active CD and inversely related to clinical disease activity and severity of inflammation [42] or, on the contrary, significantly more decreased in inactive than active IBD [38] and strongly positively correlated with CRP [26]. This evidence concerns the gene SOD1 and inflammatory bowel disease.